John P Richard's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 26,074 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 26,074 | 26,074 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 18,443 | 122,205 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 14,494 | 103,762 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Mar 2025 | 14,439 | 107,766 (0%) | 0% | 42.1 | 607,882 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.94 per share. | 01 Mar 2025 | 31 | 108,428 (0%) | 0% | 42.9 | 1,331 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 31,400 | 31,400 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 17,800 | 92,544 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 53.76 per share. | 01 Mar 2024 | 4,173 | 89,268 (0%) | 0% | 53.8 | 224,340 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 957 | 93,501 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 01 Mar 2024 | 60 | 93,441 (0%) | 0% | 53.7 | 3,221 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 18 May 2023 | 2,012 | 74,744 (0%) | 0% | 50 | 100,600 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,400 | 39,400 | - | - | 3/1/2023 | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 22,000 | 83,929 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale or transfer of securities back to the company at price $ 45.65 per share. | 01 Mar 2023 | 4,014 | 76,160 (0%) | 0% | 45.6 | 183,239 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 45.26 per share. | 01 Mar 2023 | 3,755 | 80,174 (0%) | 0% | 45.3 | 169,951 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,663 | 61,929 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 24,900 | 24,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,000 | 59,266 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 Mar 2022 | 4,498 | 45,266 (0%) | 0% | 66.6 | 299,657 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 81.14 per share. | 14 Oct 2021 | 358 | 49,764 (0%) | 0% | 81.1 | 29,048 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 113.69 per share. | 06 May 2021 | 363 | 50,122 (0%) | 0% | 113.7 | 41,269 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 138.17 per share. | 01 Mar 2021 | 6,198 | 50,237 (0%) | 0% | 138.2 | 856,378 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 5,500 | 51,799 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 4,636 | 56,435 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 88.00 per share. | 14 Oct 2020 | 262 | 46,299 (0%) | 0% | 88 | 23,056 | Common Stock |
| Ultragenyx Pharmaceutical ... | John Richard Pinion | See Remarks | Sale of securities on an exchange or to another person at price $ 94.47 per share. | 12 Oct 2020 | 2,780 | 46,561 (0%) | 0% | 94.5 | 262,627 | Common Stock |